Skip to main content

Table 3 Fluctuation of recipients’ serum creatinine and eGFR vs. donors’ hemoglobin

From: Impact of the donor-recipient gender matching on the graft survival from live donors

 

Time

Male to Male (Means ± SD)

Male to Female (Means ± SD)

Female to Female (Means ± SD)

Female to Male (Means ± SD)

Total

p-value

Serum Creatinine in Graft Recipients

One week after transplant

1.72 ± 1.48

1.60 ± 1.46

1.59 ± 1.66

1.65 ± 1.56

1.67 ± 1.66

0.474

One month after transplant

1.72 ± 1.41

1.51 ± 1.23

1.53 ± 1.40

1.56 ± 0.89

1.63 ± 1.32

0.009*

Six months after transplant

1.42 ± 0.65

1.24 ± 0.69

1.21 ± 0.45

1.61 ± 0.93

1.37 ± 0.69

0.000*

One year after transplant

1.42 ± 0.58

1.22 ± 0.56

1.32 ± 0.91

1.57 ± 0.92

1.37 ± 0.66

0.000*

eGFR in Graft Recipients

One month after transplant

61.64 ± 21.76

53.16 ± 21.58

52.69 ± 22.04

58.78 ± 21.73

58.31 ± 22.08

0.000*

Six months after transplant

66.35 ± 21.28

57.10 ± 19.68

55.23 ± 19.35

57.69 ± 23.07

62.04 ± 21.39

0.000*

One year after transplant

66.12 ± 19.99

57.59 ± 20.39

55.44 ± 22.65

58.85 ± 22.60

62.18 ± 21.05

0.000*

Hemoglobin of Graft Donors

Before surgery

15.10 ± 1.28

15.05 ± 1.30

12.89 ± 1.24

12.83 ± 1.17

14.66 ± 1.54

0.000*

After surgery

14.00 ± 1.33

13.92 ± 1.42

12.10 ± 1.30

12.03 ± 1.26

13.61 ± 1.54

0.000*

Two days after surgery

13.86 ± 1.49

13.82 ± 1.34

11.83 ± 1.32

11.71 ± 1.21

13.45 ± 1.63

0.000*

  1. *p-value< 0.05 is considered as significant. P-value is estimated by Anova